Literature DB >> 24050945

Interactions of PPAR-alpha and adenosine receptors in hypoxia-induced angiogenesis.

Yasmeen Q Rizvi1, Chander S Mehta, Adebayo Oyekan.   

Abstract

Hypoxia and adenosine are known to upregulate angiogenesis; however, the role of peroxisome proliferator-activated receptor alpha (PPARα) in angiogenesis is controversial. Using transgenic Tg(fli-1:EGFP) zebrafish embryos, interactions of PPARα and adenosine receptors in angiogenesis were evaluated under hypoxic conditions. Epifluorescent microscopy was used to assess angiogenesis by counting the number of intersegmental (ISV) and dorsal longitudinal anastomotic vessel (DLAV) at 28 h post-fertilization (hpf). Hypoxia (6h) stimulated angiogenesis as the number of ISV and DLAV increased by 18-fold (p<0.01) and 100 ± 8% (p<0.001), respectively, at 28 hpf. Under normoxic and hypoxic conditions, WY-14643 (10 μM), a PPARα activator, stimulated angiogenesis at 28 hpf, while MK-886 (0.5 μM), an antagonist of PPARα, attenuated these effects. Compared to normoxic condition, adenosine receptor activation with NECA (10 μM) promoted angiogenesis more effectively under hypoxic conditions. Involvement of A2B receptor was implied in hypoxia-induced angiogenesis as MRS-1706 (10nM), a selective A2B antagonist attenuated NECA (10 μM)-induced angiogenesis. NECA- or WY-14643-induced angiogenesis was also inhibited by miconazole (0.1 μM), an inhibitor of epoxygenase dependent production of eicosatrienoic acid (EET) epoxide. Thus, we conclude that: activation of PPARα promoted angiogenesis just as activation of A2B receptors through an epoxide dependent mechanism.
© 2013.

Entities:  

Keywords:  5′-N-ethylcarboxamidoadenosine; Adenosine receptors; Angiogenesis; CYP2C9; DLAV; EET; Eicosatrienoic acid; HIF-1α; IL-8; ISV; NECA; PGAR; PPARα; PPARγ; PPARγ angiopoietin-related gene; TSP-1; Tg(fli-1:EGFP); Zebrafish; cytochrome P450 2C9; dorsal longitudinal anastomotic vessel; eicosatrienoic acid; hour post-fertilization; hpf; hypoxia-inducible factor-1 alpha; interleukin-8; intersegmental vessel; peroxisome proliferator-activated receptor alpha; peroxisome proliferator-activated receptor gamma; thrombospondin-1; transgenic friendly leukemia integration-1 enhanced green fluorescent protein

Mesh:

Substances:

Year:  2013        PMID: 24050945      PMCID: PMC3876467          DOI: 10.1016/j.vph.2013.09.001

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  47 in total

1.  Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation.

Authors:  Igor Feoktistov; Anna E Goldstein; Sergey Ryzhov; Dewan Zeng; Luiz Belardinelli; Tatyana Voyno-Yasenetskaya; Italo Biaggioni
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

2.  Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation.

Authors:  J M Huss; F H Levy; D P Kelly
Journal:  J Biol Chem       Date:  2001-05-22       Impact factor: 5.157

3.  Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia.

Authors:  S Narravula; S P Colgan
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

4.  Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886.

Authors:  J P Kehrer; S S Biswal; E La; P Thuillier; K Datta; S M Fischer; J P Vanden Heuvel
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

Review 5.  Peroxisome proliferator-activated receptors in the cardiovascular system.

Authors:  D Bishop-Bailey
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

6.  Down-regulation of vascular endothelial growth factor expression after A(2A) adenosine receptor activation in PC12 pheochromocytoma cells.

Authors:  M E Olah; F L Roudabush
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

Review 7.  Angiogenesis: regulators and clinical applications.

Authors:  S Liekens; E De Clercq; J Neyts
Journal:  Biochem Pharmacol       Date:  2001-02-01       Impact factor: 5.858

8.  PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation.

Authors:  Markus Meissner; Monika Stein; Carmen Urbich; Kerstin Reisinger; Guntram Suske; Bart Staels; Roland Kaufmann; Jens Gille
Journal:  Circ Res       Date:  2003-12-18       Impact factor: 17.367

Review 9.  Peroxisome proliferator-activated receptors and angiogenesis.

Authors:  F Biscetti; G Straface; D Pitocco; F Zaccardi; G Ghirlanda; A Flex
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-07-23       Impact factor: 4.222

10.  Comparative analysis of the in vivo angiogenic properties of stable prostacyclin analogs: a possible role for peroxisome proliferator-activated receptors.

Authors:  R Pola; E Gaetani; A Flex; T R Aprahamian; M Bosch-Marcé; D W Losordo; R C Smith; P Pola
Journal:  J Mol Cell Cardiol       Date:  2004-03       Impact factor: 5.000

View more
  8 in total

1.  Cortical Thickness of Native Tibetans in the Qinghai-Tibetan Plateau.

Authors:  W Wei; X Wang; Q Gong; M Fan; J Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2017-01-19       Impact factor: 3.825

2.  Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.

Authors:  Jennifer L Parker-Duffen; Kazuto Nakamura; Marcy Silver; Maria A Zuriaga; Susan MacLauchlan; Tamar R Aprahamian; Kenneth Walsh
Journal:  J Biol Chem       Date:  2014-04-17       Impact factor: 5.157

3.  BK channel-forming slo1 proteins mediate the brain artery constriction evoked by the neurosteroid pregnenolone.

Authors:  Kelsey C North; Anna N Bukiya; Alex M Dopico
Journal:  Neuropharmacology       Date:  2021-05-21       Impact factor: 5.273

4.  Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.

Authors:  Ewa Szalowska; Haftu A Tesfay; Sacha A F T van Hijum; Sander Kersten
Journal:  BMC Genomics       Date:  2014-12-15       Impact factor: 3.969

5.  Modulation of membrane lipid composition and homeostasis in salmon hepatocytes exposed to hypoxia and perfluorooctane sulfonamide, given singly or in combination.

Authors:  Marianne Olufsen; Maria V Cangialosi; Augustine Arukwe
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

6.  Multifaceted Mechanisms of WY-14643 to Stabilize the Blood-Brain Barrier in a Model of Traumatic Brain Injury.

Authors:  Winfried Neuhaus; Tobias Krämer; Anja Neuhoff; Christina Gölz; Serge C Thal; Carola Y Förster
Journal:  Front Mol Neurosci       Date:  2017-05-26       Impact factor: 5.639

7.  Inflammation-coagulation response and thrombotic effects induced by silica nanoparticles in zebrafish embryos.

Authors:  Junchao Duan; Shuang Liang; Yang Yu; Yang Li; Lijing Wang; Zehao Wu; Yueyue Chen; Mark R Miller; Zhiwei Sun
Journal:  Nanotoxicology       Date:  2018-04-14       Impact factor: 5.913

8.  DNMT1-mediated PPARα methylation aggravates damage of retinal tissues in diabetic retinopathy mice.

Authors:  Ying Zhu; Xinru Wang; Xiaoyun Zhou; Lexi Ding; Dan Liu; Huizhuo Xu
Journal:  Biol Res       Date:  2021-08-06       Impact factor: 5.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.